372 related articles for article (PubMed ID: 31801934)
1. Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.
Toyoda K; Koga M; Iguchi Y; Itabashi R; Inoue M; Okada Y; Ogasawara K; Tsujino A; Hasegawa Y; Hatano T; Yamagami H; Iwama T; Shiokawa Y; Terayama Y; Minematsu K
Neurol Med Chir (Tokyo); 2019 Dec; 59(12):449-491. PubMed ID: 31801934
[No Abstract] [Full Text] [Related]
2. Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society.
Minematsu K; Toyoda K; Hirano T; Kimura K; Kondo R; Mori E; Nakagawara J; Sakai N; Shiokawa Y; Tanahashi N; Yasaka M; Katayama Y; Miyamoto S; Ogawa A; Sasaki M; Suga S; Yamaguchi T;
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):571-600. PubMed ID: 23727456
[TBL] [Abstract][Full Text] [Related]
3. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of alteplase in the treatment of acute ischemic stroke.
Micieli G; Marcheselli S; Tosi PA
Vasc Health Risk Manag; 2009; 5(1):397-409. PubMed ID: 19475777
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
7. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals.
Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ
J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic stroke: decide rapidly.
Prescrire Int; 2015 Sep; 24(163):221. PubMed ID: 26417638
[TBL] [Abstract][Full Text] [Related]
9. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
Weintraub MI
Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683
[TBL] [Abstract][Full Text] [Related]
11. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.
Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K
Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
14. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
[TBL] [Abstract][Full Text] [Related]
16. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
[TBL] [Abstract][Full Text] [Related]
17. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
18. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute ischemic stroke: systemic or local?
von Kummer R; Gerber J
Ann N Y Acad Sci; 2012 Sep; 1268():79-84. PubMed ID: 22994225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
